Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro. [electronic resource]
Producer: 20170123Description: 16-23 p. digitalISSN:- 1095-8355
- Antigens, CD34 -- metabolism
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Etoposide -- pharmacology
- Gene Expression Regulation, Leukemic -- drug effects
- Humans
- Imatinib Mesylate -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Neoplastic Stem Cells -- drug effects
- Signal Transduction -- drug effects
- Topoisomerase II Inhibitors -- pharmacology
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.